Main Menu

Livongo Health, Inc.

(NASDAQ GS: LVGO)

Summary

Attention investors who purchased shares of Livongo Health, Inc. before August 5, 2020:

Rigrodsky & Long is investigating potential claims against the board of directors of Livongo Health, Inc. concerning possible breaches of fiduciary duty and other violations of law related to the Company’s agreement to merge with Teladoc Health, Inc.

Press Release

Rigrodsky & Long, P.A. announces that it is investigating Livongo Health, Inc. (“Livongo”) (NASDAQ GS: LVGO) regarding possible breaches of fiduciary duties and other violations of law related to Livongo’s agreement to merge with Teladoc Health, Inc. ("Teladoc") (NYSE: TDOC). Under the terms of the agreement, shareholders of Livongo will receive 0.592 of a share of Teladoc and a cash consideration of $11.33 for each share of Livongo they own.

If you would like to discuss this investigation and your rights cost and obligation free, please contact Seth D. Rigrodsky or Gina M. Serra toll free at (888) 969-4242 or by e-mail at info@rl-legal.com. 

Rigrodsky & Long, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.

Attorney advertising.  Prior results do not guarantee a similar outcome.

Back to Page